ダウンロード数: 173
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
24_0609.pdf | 1.8 MB | Adobe PDF | 見る/開く |
タイトル: | 前立腺肥大症に対するPhenoxybenzamineの使用経験 |
その他のタイトル: | CLINICAL STUDIES ON PHENOXYBENZAMINE IN-THE TREATMENT OF BENIGN PROSTATIC HYPERTROPHY |
著者: | 勝見, 哲郎 中島, 慎一 川口, 光平 村山, 和夫 北川, 清隆 金田, 泰雄 黒田, 恭一 |
著者名の別形: | Katsumi, Tetsuo Nakajima, Shinichi Kawaguchi, Kohei Murayama, Kazuo Kitagawa, Kiyotaka Kaneda, Yasuo Kuroda, Kyoichi |
発行日: | Jul-1978 |
出版者: | 京都大学医学部泌尿器科学教室 |
誌名: | 泌尿器科紀要 |
巻: | 24 |
号: | 7 |
開始ページ: | 609 |
終了ページ: | 616 |
抄録: | Seventeen patients with benign prostatic hypertrophy have been treated by an oral administration of phenoxybenzamine (POB) 5 mg daily for 14 days. The effectiveness was determined by scoring the relief degree of symptoms or complaints related to micturition, and by physical findings such as the amount of residual urine, uroflowmetric and cystometric patterns, and urethral pressure profile. The results obtained are as follows: 1. Relief of the symptoms or complaints was obtained in 12 patients (70.6%), and the decrease of nocturnal frequency in 13 patients (76.5%) (p<0.01). 2. The decrease of residual urine was obtained in 12 patients (70.6%). 3. The estimation of posterior urethral pressure was undertaken in 4 patients and there was no significant decrease after the administration. 4. Neither subjective nor objective side effects were observed in the patients. From the results, POB was considered a useful drug in the conservative treatment of benign prostatic hypertrophy. |
URI: | http://hdl.handle.net/2433/122228 |
出現コレクション: | Vol.24 No.7 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。